Eprociclovir

N/A

Report date: 2022/12/07 17:15:45

Base Information

Drug NameEprociclovir

Drug Alias NameA-5021

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues

Mechanisms of ActionDNA-directed DNA polymerase inhibitors

TargetsDNA-directed DNA polymerase

Therapy Area/IndicationsHerpes Simplex

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAjinomoto Co Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAjinomoto Co Inc

Active IndicationsN/A

Inactive IndicationsHerpes Simplex

ATC CodeN/A